If you're already at Costco in the next several weeks stocking up on essentials for holiday feasting, consider a highly-rated item that sets you up for success with the most thorny aspect of festive ...

An experimental drug compound could be a promising treatment for harmful diabetes complications, per a new study in lab mice and human cells. When you purchase through links on our site, we may earn ...

Forbes contributors publish independent expert analyses and insights. Hank Cardello covers issues impacting food companies and consumers. The White House’s MAHA plan targets ultra-processed foods and ...

I’m sharing my simple approach to healthy eating and weight loss by breaking down balanced meals with correct portions of protein, carbs, vegetables, and fats. I show how easy it is to plate delicious ...

Darden Restaurants is experimenting with smaller servings at Olive Garden, testing out a "Lighter Portion Entrées" menu across 40% of its locations, the company announced in its quarterly earnings ...

A large portion of the global population with diabetes remains undiagnosed or is not receiving optimal care, according to a new study published in The Lancet Diabetes & Endocrinology. The Institute ...

CLEVELAND, Ohio — When artificial intelligence provides health-coaching to adults with Type 2 diabetes, it can significantly improve their ability to control blood sugar, a new Cleveland Clinic study ...

In this video, I share my personal experience with portion control and how it’s helped me build healthier eating habits for life—not just for weight loss. I explain the practical steps I use, the ...

Share on Pinterest Turmeric are supplements linked to better weight control in diabetes, evidence suggests. Image credit: Bahadur Ali/Getty Images Type 2 diabetes is a major global health concern — in ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Use of an AI-based smartphone app helped adults with ...

Glycemic control improved with increased diabetes technology use, yet overall control remains low among T1D patients in the US. Significant disparities in glycemic control and technology use persist ...